AZN.L |
ASTRAZENECA PLC |
|
5.73% |
|
|
|
|
|
|
|
|
|
---|
GILD |
Gilead Sciences, Inc. |
0 |
5.60% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
27.52% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
4.95% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
---|
ARGX |
argenx SE |
0 |
4.89% |
|
|
|
|
|
N/A |
0.00% |
29.52% |
28.33% |
---|
INCY |
Incyte Corporation |
0 |
4.43% |
|
|
|
|
|
N/A |
0.00% |
29.49% |
27.75% |
---|
RVMD |
Revolution Medicines, Inc. |
0 |
4.24% |
|
|
|
|
|
N/A |
0.00% |
54.00% |
42.22% |
---|
BPMC |
Blueprint Medicines Corporation |
0 |
4.23% |
|
|
|
|
|
N/A |
0.00% |
94.29% |
1.14% |
---|
ILMN |
Illumina, Inc. |
0 |
4.06% |
|
|
|
|
|
N/A |
0.00% |
39.56% |
23.84% |
---|
4519.T |
CHUGAI PHARMACEUTICAL CO., LTD. |
|
3.86% |
|
|
|
|
|
|
|
|
|
---|
EXEL |
Exelixis, Inc. |
0 |
3.51% |
|
|
|
|
|
N/A |
0.00% |
32.60% |
25.01% |
---|
4568.T |
DAIICHI SANKYO CO., LTD. |
|
3.10% |
|
|
|
|
|
|
|
|
|
---|
MREO |
Mereo BioPharma Group plc |
0 |
2.75% |
|
|
|
|
|
N/A |
0.00% |
247.17% |
46.42% |
---|
GMAB |
Genmab A/S |
0 |
2.61% |
|
|
|
|
|
N/A |
0.00% |
125.36% |
33.50% |
---|
BGNE |
BEIGENE LTD. |
|
2.40% |
|
|
|
|
|
|
|
|
|
---|
MRK |
Merck & Co., Inc. |
0 |
2.38% |
|
|
|
|
|
N/A |
0.00% |
28.04% |
24.62% |
---|
SWTX |
SPRINGWORKS THERAPEUTICS, INC. |
|
2.36% |
|
|
|
|
|
|
|
|
|
---|
GH |
Guardant Health, Inc. |
0 |
2.32% |
|
|
|
|
|
N/A |
0.00% |
62.38% |
26.94% |
---|
CRSP |
CRISPR Therapeutics AG |
0 |
2.18% |
|
|
|
|
|
N/A |
0.00% |
57.68% |
34.39% |
---|
NOVN.SW |
NOVARTIS AG |
|
2.13% |
|
|
|
|
|
|
|
|
|
---|
NUVL |
Nuvalent, Inc. |
0 |
1.97% |
|
|
|
|
|
N/A |
0.00% |
46.28% |
35.21% |
---|
DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
1.90% |
|
|
|
|
|
N/A |
0.00% |
603.44% |
78.76% |
---|
EXAS |
Exact Sciences Corporation |
0 |
1.82% |
|
|
|
|
|
N/A |
0.00% |
61.77% |
68.33% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
0 |
1.81% |
|
|
|
|
|
N/A |
0.00% |
50.34% |
51.96% |
---|
CLDX |
Celldex Therapeutics, Inc. |
0 |
1.58% |
|
|
|
|
|
N/A |
0.00% |
88.72% |
52.03% |
---|
LNTH |
Lantheus Holdings, Inc. |
0 |
1.55% |
|
|
|
|
|
N/A |
0.00% |
68.99% |
71.45% |
---|
AMGN |
Amgen Inc. |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
---|
SDGR |
Schrödinger, Inc. |
0 |
1.45% |
|
|
|
|
|
N/A |
0.00% |
79.24% |
60.12% |
---|
NTLA |
Intellia Therapeutics, Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
92.06% |
42.42% |
---|
SHL.DE |
SIEMENS HEALTHINEERS AG |
|
1.36% |
|
|
|
|
|
|
|
|
|
---|
MRUS |
Merus N.V. |
0 |
1.29% |
|
|
|
|
|
N/A |
0.00% |
67.26% |
39.10% |
---|
ACLX |
Arcellx, Inc. |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
50.16% |
23.91% |
---|
BNTX |
BioNTech SE |
0 |
1.08% |
|
|
|
|
|
N/A |
0.00% |
43.87% |
30.54% |
---|
SMMT |
Summit Therapeutics Inc. |
0 |
1.02% |
|
|
|
|
|
N/A |
0.00% |
82.88% |
23.35% |
---|
NRIX |
Nurix Therapeutics, Inc. |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
285.85% |
33.99% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
225.35% |
14.69% |
---|
COGT |
Cogent Biosciences, Inc. |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
164.12% |
20.30% |
---|
MRNA |
Moderna, Inc. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
56.54% |
10.47% |
---|
ORIC |
ORIC Pharmaceuticals, Inc. |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
855.71% |
18.57% |
---|
LEGN |
Legend Biotech Corporation |
0 |
0.78% |
|
|
|
|
|
N/A |
0.00% |
49.87% |
20.04% |
---|
CGEM |
Cullinan Oncology, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
816.30% |
63.58% |
---|
RCUS |
Arcus Biosciences, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
541.51% |
49.96% |
---|
IMCR |
Immunocore Holdings plc |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
87.98% |
27.58% |
---|
BCYC |
Bicycle Therapeutics plc |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
1,304.54% |
37.54% |
---|
JANX |
Janux Therapeutics, Inc. |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
90.33% |
49.69% |
---|
RLAY |
Relay Therapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
210.16% |
46.04% |
---|
TERN |
Terns Pharmaceuticals, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
124.25% |
34.89% |
---|
JSPR |
Jasper Therapeutics, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
393.32% |
82.68% |
---|
CGON |
CG Oncology, Inc. Common stock |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
185.01% |
21.54% |
---|
ARVN |
Arvinas, Inc. |
0 |
0.39% |
|
|
|
|
|
N/A |
0.00% |
91.41% |
16.49% |
---|
CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
0 |
N/A |
|
|
|
|
|
N/A |
0.00% |
137.46% |
47.17% |
---|